Burcin Simsek
Burcin Simsek
pitt.edu üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
B Geoerger, C Bergeron, L Gore, L Sender, IJ Dunkel, C Herzog, ...
European Journal of Cancer 86, 358-363, 2017
402017
Which sleep health characteristics predict all-cause mortality in older men? An application of flexible multivariable approaches
ML Wallace, K Stone, SF Smagula, MH Hall, B Simsek, DM Kado, ...
Sleep 41 (1), zsx189, 2018
212018
An asymptotic expansion for the normalizing constant of the Conway–Maxwell–Poisson distribution
RE Gaunt, S Iyengar, ABO Daalhuis, B Simsek
Annals of the Institute of Statistical Mathematics 71 (1), 163-180, 2019
152019
A phase 3, randomized, open-label study of nivolumab combined with cabozantinib vs sunitinib in patients with previously untreated advanced or metastatic renal cell carcinoma …
TK Choueiri, AB Apolo, T Powles, B Escudier, OR Aren, A Shah, ...
Journal of Clinical Oncology 36 (15_suppl), TPS4598-TPS4598, 2018
152018
Approximating the Conway-Maxwell-Poisson normalizing constant
B Şimşek, S Iyengar
Filomat 30 (4), 953-960, 2016
122016
Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study
Y Tomita, S Fukasawa, N Shinohara, H Kitamura, M Oya, M Eto, K Tanabe, ...
Japanese journal of clinical oncology 49 (6), 506-514, 2019
102019
The computation of expected values and moments of special polynomials via characteristic and generating functions
B Simsek, B Simsek
AIP Conference Proceedings 1863 (1), 300012, 2017
52017
On the distribution of photon counts with censoring in two-photon laser scanning microscopy
B Simsek, S Iyengar
Journal of Mathematical Imaging and Vision 58 (1), 47-56, 2017
52017
Applications of point process models to imaging and biology
B Simsek
University of Pittsburgh, 2016
52016
An approach to negative hypergeometric distribution by generating function for special numbers and polynomials
İ KÜÇÜKOĞLU, B ŞİMŞEK, Y ŞİMŞEK
Turkish Journal of Mathematics 43 (5), 2337-2353, 2019
42019
An approach to revealing clinically relevant subgroups across the mood spectrum
ML Wallace, B Simsek, DJ Kupfer, HA Swartz, A Fagiolini, E Frank
Journal of affective disorders 203, 265-274, 2016
32016
Application of multilevel analysis in animal sciences
B Simsek, MZ Firat
Applied Mathematics and Computation 218 (3), 1067-1071, 2011
32011
Generating Functions for New Families of Combinatorial Numbers and Polynomials: Approach to Poisson–Charlier Polynomials and Probability Distribution Function
I Kucukoglu, B Simsek, Y Simsek
Axioms 8 (4), 112, 2019
22019
Phase II study of ipilimumab (IPI) in children and adolescents with unresectable stage III or IV malignant melanoma (MEL).
AS Pappo, C Bergeron, L Gore, LS Sender, IJ Dunkel, CE Herzog, ...
Journal of Clinical Oncology 35 (15_suppl), e21006-e21006, 2017
22017
A step towards the automation of intracytoplasmic sperm injection: real time confirmation of mouse and human oocyte penetration and viability by electrical resistance measurement
A Mor, M Zhang, E Esencan, B Simsek, SM Nichols-Burns, Y Liu, J Lo, ...
Fertility and Sterility 113 (1), 234-236, 2020
12020
Overall survival at 5 years of follow-up from a phase 3 trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
PA Ascierto, M Del Vecchio, A Mackiewicz, C Robert, V Chiarion-Sileni, ...
Journal of Translational Medicine 17 (1), O23, 2019
12019
On Certain Mathematical Problems in Two-Photon Laser Scanning Microscopy
B Simsek, S Iyengar
Mathematical Modelling and Analysis 22 (5), 587-600, 2017
12017
DISPARITIES IN ART LIVE-BIRTH OUTCOMES FOR HISPANIC AND ASIAN WOMEN COMPARED TO WHITE NON-HISPANIC WOMEN.
A Kotlyar, B Simsek, DB Seifer
ASRM 2020 Virtual Scientific Congress & Expo, 2020
2020
Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial
P Sharma, RK Pachynski, V Narayan, A Fléchon, G Gravis, MD Galsky, ...
Cancer Cell, 2020
2020
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
PA Ascierto, M Del Vecchio, A Mackiewicz, C Robert, V Chiarion-Sileni, ...
Journal for ImmunoTherapy of Cancer 8 (1), e000391, 2020
2020
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20